|
Volumn 17, Issue 12, 1998, Pages 1213-1219
|
Bezafibrate and lovastatin decrease the oxidizability of low-density lipoproteins in heart transplant recipients with hyperlidemia
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BEZAFIBRATE;
CHOLESTEROL;
CYCLOSPORIN;
GLUCOSE;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
INSULIN;
LIPID;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
MEVINOLIN;
MONOUNSATURATED FATTY ACID;
OXIDIZED LOW DENSITY LIPOPROTEIN;
POLYUNSATURATED FATTY ACID;
TRIACYLGLYCEROL;
ADULT;
ARTICLE;
CARDIOMYOPATHY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
CROSSOVER PROCEDURE;
DIET;
FEMALE;
HEART TRANSPLANTATION;
HUMAN;
HYPERLIPIDEMIA;
INSULINEMIA;
LIPID COMPOSITION;
LIPID OXIDATION;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RECIPIENT;
ANTILIPEMIC AGENTS;
BEZAFIBRATE;
CROSS-OVER STUDIES;
FEMALE;
HEART TRANSPLANTATION;
HUMANS;
HYPERLIPIDEMIAS;
LIPOPROTEINS, LDL;
LOVASTATIN;
MALE;
MIDDLE AGED;
OXIDATION-REDUCTION;
PROSPECTIVE STUDIES;
|
EID: 0032412371
PISSN: 10532498
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (14)
|
References (40)
|